Chairman, President and CEO of Quest Diagnostics Inc (DGX, Financial) Stephen H Rusckowski sold 168,490 shares of DGX on 05/25/2018 at an average price of $107 a share. The total sale was $18 million.
Quest Diagnostics Inc provides diagnostic testing, information, and services, providing insights that enable patients and physicians to make healthcare decisions. It provides diagnostics for insurers and healthcare information technology businesses. Quest Diagnostics Inc has a market cap of $14.44 billion; its shares were traded at around $106.35 with a P/E ratio of 18.95 and P/S ratio of 1.95. The dividend yield of Quest Diagnostics Inc stocks is 1.73%. Quest Diagnostics Inc had annual average EBITDA growth of 4.10% over the past ten years. GuruFocus rated Quest Diagnostics Inc the business predictability rank of 2.5-star.
CEO Recent Trades:
- Chairman, President and CEO Stephen H Rusckowski sold 168,490 shares of DGX stock on 05/25/2018 at the average price of $107. The price of the stock has decreased by 0.61% since.
CFO Recent Trades:
- Executive Vice President & CFO Mark Guinan sold 61,533 shares of DGX stock on 05/25/2018 at the average price of $105.71. The price of the stock has increased by 0.61% since.
For the complete insider trading history of DGX, click here
.
